XML 153 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details) - shares
9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
[1]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 14,951,799 15,102,501 12,181,019,000 13,501,229,000
Options To Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 147,000 913,856    
Unvested Restricted Stock Units And Awards [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,371,950 177,275    
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 12,314,114 3,112,165 12,181,019,000 2,367,607,000
Series A-1 Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,839,957 2,839,957,000
Series A-2 Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 3,415,923 3,415,923,000
Convertible Promissory Note [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,118,735 4,643,325 3,786,610,000
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents     913,856,000
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents     177,276,000
[1] Retroactively restated for the reverse recapitalization in Note 3.